Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418711
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-08
Brief Title:
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101 Clofazimine Inhalation Suspension
Sponsor:
Mannkind Corporation
Organization:
Mannkind Corporation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-08
First Submit QC Date:
May 13 2024
Study First Post Date:
2024-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-05-17
Last Update Post Date Type:
ACTUAL